CANF

CANF R&D Expense Growth

17.18%Fiscal year

Period ending:

CANF FY R&D Growth (YoY)%
CANF FY R&D Growth (YoY)93.11%-35.36%
2010-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

CANF r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 16 observations from Dec 31, 2010 to Dec 31, 2025.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
17.1807%
-3.7774%
-22.9293%
-21.1878%
-17.5801%
8.883%
80.6749%
15.24%
-13.2687%
57.6323%
-7.318%
-5.8589%
25.456%
3.3757%
20.983%
0%

Compare r&d expense growth

All CANF financial metrics · CANF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.